Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03256292 · ClinicalTrials.gov registry record
Long-term Lifestyle Change and Testosterone Replacement
A clinical trial, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- 38
- Enrollment target
NCT03256292: Completed study, sponsored by Baylor College of Medicine.
NCT03256292 is a clinical trial that has completed, run by Baylor College of Medicine. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03256292 has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
Older hypogonadal obese veterans previously participated in a 6 month lifestyle change (diet-induced weight loss and exercise) study with or without testosterone replacement therapy before being followed for the following year at the clinic while receiving standard of care consisting of diet and exercise counseling (for healthy lifestyle change) and testosterone replacement therapy. This study will determine if long-term lifestyle change and testosterone replacement therapy with associated improvement in physical and metabolic health can be maintained in obese older adults.
Primary Outcome
The primary functional outcome is the modified physical performance test, which includes seven standardized tasks (walking 50 ft, putting on and removing a coat, picking up a penny, standing up from a chair, lifting a book, climbing one flight of stairs, and performing a progressive Romberg tests) plus two additional tasks (climbing up and down four flights of stairs and performing a 360-degree turn). The score for each task ranges form 0 to 4; a perfect score is 36.
Interventions
- DRUG Testosterone replacement
- BEHAVIORAL lifestyle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2017-08-21 |
| Est. Completion | 2020-08-31 |
What the finished NCT03256292 record still lists
NCT03256292 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Testosterone replacement is the first listed.
NCT03256292 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03256292 about?
NCT03256292 is a clinical study titled "Long-term Lifestyle Change and Testosterone Replacement". Older hypogonadal obese veterans previously participated in a 6 month lifestyle change (diet-induced weight loss and exercise) study with or without testosterone replacement therapy before being followed for the following year at the clinic while receiving standard of care consisting of diet and exe...
What is the current status of trial NCT03256292?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2017-08-21. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT03256292?
The interventions under investigation include: Testosterone replacement (DRUG), lifestyle (BEHAVIORAL).
Who is sponsoring clinical trial NCT03256292?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI